Results 271 to 280 of about 66,702 (306)
Some of the next articles are maybe not open access.
Australian and New Zealand Journal of Medicine, 1987
Abstract An 80‐year‐old woman developed acute hepatitis following her first exposure to nifedipine. This adverse effect was characterised by fever, chills, anorexia, nausea, liver tenderness, hepatitic liver function tests and peripheral blood eosinophilia.
D R, Shaw, G M, Misan, R D, Johnson
openaire +2 more sources
Abstract An 80‐year‐old woman developed acute hepatitis following her first exposure to nifedipine. This adverse effect was characterised by fever, chills, anorexia, nausea, liver tenderness, hepatitic liver function tests and peripheral blood eosinophilia.
D R, Shaw, G M, Misan, R D, Johnson
openaire +2 more sources
The American Journal of Medicine, 1986
A 59-year-old man ingested 900 mg of nifedipine. Profound hypotension, sinus and atrioventricular node dysfunction, and hyperglycemia resulted. The patient's condition responded favorably to aggressive treatment with intravenous fluids, calcium, and dopamine.
D M, Herrington +2 more
openaire +2 more sources
A 59-year-old man ingested 900 mg of nifedipine. Profound hypotension, sinus and atrioventricular node dysfunction, and hyperglycemia resulted. The patient's condition responded favorably to aggressive treatment with intravenous fluids, calcium, and dopamine.
D M, Herrington +2 more
openaire +2 more sources
The American Journal of Cardiology, 1985
Many investigators have studied the potential interactions between calcium-channel antagonists and digoxin. Digoxin is usually well absorbed, and its excretion is dependent on renal mechanisms, primarily glomerular filtration. Several studies have reported a decrease in digoxin clearance and an increase of approximately 50% in digoxin levels when ...
openaire +3 more sources
Many investigators have studied the potential interactions between calcium-channel antagonists and digoxin. Digoxin is usually well absorbed, and its excretion is dependent on renal mechanisms, primarily glomerular filtration. Several studies have reported a decrease in digoxin clearance and an increase of approximately 50% in digoxin levels when ...
openaire +3 more sources
Nifedipine-Aminophylline Interaction
Survey of Anesthesiology, 1988Two patients suffered serious nifedipine side effects that were reversed by intravenous ...
L. Kalra, S. J. P. Ariaraj, M. F. Bone
openaire +3 more sources
Nifedipine and Erythromelalgia
Annals of Internal Medicine, 1983Excerpt To the editor: Erythromelalgia, a skin eruption with intense red discoloration, elevated skin temperature, and burning pain, usually involves the hands, feet, or lower legs.
Marvin B. Padnick +2 more
openaire +4 more sources
Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth
The Lancet, 1992The mechanism of gingival overgrowth associated with long-term use of nifedipine and of other drugs that affect calcium homoeostasis, such as cyclosporin and phenytoin, is unknown. With an ultrasensitive assay, we measured the pharmacokinetics of nifedipine in plasma and gingival crevicular fluid (GCF) of nine patients receiving this drug for angina ...
Janice S. Ellis +3 more
openaire +3 more sources
Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes
International Journal of Pharmaceutics, 1996Chitosan microspheres of nifedipine and nifedipine cyclodextrin complexes were prepared by the glutaraldehyde cross-linking of chitosan. Microspheres having different degrees of swelling were made by varying the cross-linking density. Drug incorporation efficiencies exceeding 70 % could be achieved for this drug.
Ivan Jalšenjak +3 more
openaire +3 more sources
Pharmacokinetics of nifedipine.
International journal of clinical pharmacology research, 1985The pharmacokinetics of a slow-release formulation of nifedipine were studied following oral administration of a single 20 mg tablet in nine young male volunteers. Blood samples were collected and nifedipine concentrations analysed by gas liquid chromatography.
PASANISI, FABRIZIO +2 more
openaire +2 more sources
Nifedipine in the treatment of hypertension
European Journal of Clinical Pharmacology, 1983Nifedipine, a calcium antagonist with a predominant vasodilator action, was evaluated for the treatment of hypertension. A 20 mg-tablet, with a slower absorption and a more sustained blood-level than provided by the 10 mg-capsule was administered to 20 patients. The duration of the trial was 20 weeks.
S. Blake +3 more
openaire +3 more sources
Nifedipine in Antihypertensive Therapy
Archives of Internal Medicine, 1985To the Editor. —We read with interest the article by Evans et al 1 in the May 1984Archives. Their results are similar to ours in demonstrating nifedipine efficacy as a substitute for hydralazine and captopril in combination antihypertensive therapy. 2 Recently, McAreavey et al 3 suggested hydralazine as the best third-line drug.
Ehud Grossman +2 more
openaire +3 more sources